Baron Asset Fund adds CBRS and EW; exits FICO and FND
Seeking Alpha News (Tue, 8-Sep 7:55 AM ET)
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Mon, 7-Sep 3:32 PM ET)
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
Business Wire (Wed, 2-Sep 4:15 PM ET)
Market Chameleon (Fri, 24-Jul 3:06 AM ET)
Edwards Lifesciences Reports Second Quarter Results
Business Wire (Thu, 23-Jul 4:15 PM ET)
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
Business Wire (Thu, 16-Jul 7:05 AM ET)
Business Wire (Fri, 26-Jun 10:15 AM ET)
Edwards Lifesciences Sets Stage for Key Insights at J.P. Morgan Healthcare Conference
Market Chameleon (Thu, 18-Dec 3:23 AM ET)
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Edwards Lifesciences trades on the NYSE stock market under the symbol EW.
As of September 9, 2026, EW stock price declined to $86.18 with 2,257,261 million shares trading.
EW has a beta of 0.59, meaning it tends to be less sensitive to market movements. EW has a correlation of 0.09 to the broad based SPY ETF.
EW has a market cap of $49.67 billion. This is considered a Large Cap stock.
Last quarter Edwards Lifesciences reported $2 billion in Revenue and $.78 earnings per share. This beat revenue expectation by $41 million and exceeded earnings estimates by $.04.
In the last 3 years, EW traded as high as $96.29 and as low as $58.93.
The top ETF exchange traded funds that EW belongs to (by Net Assets): VTI, VOO, VO, SPY, VTV.
EW has underperformed the market in the last year with a price return of +7.4% while the SPY ETF gained +18.7%. EW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +0.4% and -5.2%, respectively, while the SPY returned +3.4% and -0.5%, respectively.
EW support price is $85.48 and resistance is $87.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EW shares will trade within this expected range on the day.
